FDA endorses Novartis’ ‘pipeline in a pill,’ granting first nod for potential blockbuster Fabhalta
Novartis has gained the first of what it hopes are several FDA approvals for its factor B inhibitor iptacopan, dubbed two months ago “a pipeline in pill,” by analyst...